pharmacovigilance

Reporting of adverse drug reactions protects users of pharmaceutical products

Adverse reactions are carefully monitored in clinical trials before a drug enters the market, and after that they remain under constant monitoring throughout the life cycle of the drug. Every report on adverse drug reactions is important for the evaluation of the safety and efficacy of a drug.

› Read more

Pharmacovigilance now and in the future – Current topics of the World Drug Safety Congress Europe

Future trends were emphasised strongly in the discussion, especially with regard to the development possibilities introduced by new technological solutions. Read the highlights of the event.

› Read more